Cord blood transplant for blood cancers in older adults
Treatments studied
Part of Blood & lymphatic, Cancer clinical trials.
This study tests a new combination of chemotherapy drugs before a cord blood transplant for people aged 60-69 with blood cancers. The goal is to see if it is safe and effective for older patients who need a transplant but may not have a matched donor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 69 years old.
- You have a blood cancer and are planning to have a single unrelated cord blood transplant.
- Your liver, kidney, heart, and lung functions are within acceptable ranges.
- You are physically able to care for yourself (ECOG score 2 or less).
- You have no other major health problems that would increase transplant risks.
- You are expected to live at least 6 more months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a second transplant using two donated umbilical cord blood units for people whose blood cancer returned after a first stem cell transplant. It aims to offer a potential cure for high-risk blood cancers.
This study tests whether using cord blood stem cells (collected from umbilical cords after birth) can help treat high-risk blood cancers in children and young adults when a matched donor is not quickly available. Cord blood transplants may help prevent cancer from coming back.
This Phase 2 trial studies using a cord blood transplant after finding it is risky enough that standard treatment may not be sufficient. It may help certain children and young adults with specific leukemia, lymphoma, and some non-cancer blood/immune or inherited disorders who do not have a well-matched donor available in time.
This trial tests a cord blood transplant using strong (myeloablative) chemotherapy to prepare your body, plus post-transplant treatment to reduce graft-versus-host disease (GVHD). It may help certain blood cancers when other transplant options are limited.
This trial tests a cord blood transplant after a reduced-intensity chemotherapy and radiation regimen for patients with high-risk blood cancers like leukemia, lymphoma, or MDS. The goal is to see if this approach can help destroy cancer cells and restore healthy blood cells.
This trial studies transplanting healthy blood-forming cells from an umbilical cord blood donor who is not related to you. It may help people with certain blood cancers, immune disorders, or other serious diseases when a standard transplant plan is needed.
Hear when a new Hematologic Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.